| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4643435
Max Phase: Preclinical
Molecular Formula: C19H23N5O
Molecular Weight: 337.43
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCCc1nc2c(N)nc3cc(C#N)ccc3c2n1CC(C)(C)O
Standard InChI: InChI=1S/C19H23N5O/c1-4-5-6-15-23-16-17(24(15)11-19(2,3)25)13-8-7-12(10-20)9-14(13)22-18(16)21/h7-9,25H,4-6,11H2,1-3H3,(H2,21,22)
Standard InChI Key: JHUUOQZNDXJMSK-UHFFFAOYSA-N
Associated Targets(Human)
Toll-like receptor 8 1853 Activities
Toll-like receptor 7 2626 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Toll-like receptor 7/8 156 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 337.43 | Molecular Weight (Monoisotopic): 337.1903 | AlogP: 3.15 | #Rotatable Bonds: 5 |
| Polar Surface Area: 100.75 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 3.52 | CX LogP: 2.98 | CX LogD: 2.98 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.74 | Np Likeness Score: -0.87 |
References
| 1. Hunt JR, Kleindl PA, Moulder KR, Prisinzano TE, Forrest ML.. (2020) Further exploration of the structure-activity relationship of imidazoquinolines; identification of potent C7-substituted imidazoquinolines., 30 (2): [PMID:31784317] [10.1016/j.bmcl.2019.126788] |
Source
Source(1):